Literature DB >> 33585273

Metabolomics Exploration of Pseudorabies Virus Reprogramming Metabolic Profiles of PK-15 Cells to Enhance Viral Replication.

Hongchao Gou1,2,3,4, Zhibiao Bian1,2,3,4, Yan Li1,2,3,4, Rujian Cai1,2,3,4, Zhiyong Jiang1,2,3,4, Shuai Song1,2,3,4, Kunli Zhang1,2,3,4, Pinpin Chu1,2,3,4, Dongxia Yang1,2,3,4, Chunling Li1,2,3,4.   

Abstract

For viral replication to occur in host cells, low-molecular-weight metabolites are necessary for virion assembly. Recently, metabolomics has shown great promise in uncovering the highly complex mechanisms associated with virus-host interactions. In this study, the metabolic networks in PK-15 cells infected with a variant virulent or classical attenuated pseudorabies virus (PRV) strains were explored using gas chromatography-mass spectrometry (GC-MS) analysis. Although total numbers of metabolites whose levels were altered by infection with the variant virulent strain or the classical attenuated strain were different at 8 and 16 h post infection (hpi), the predicted levels of differential metabolic components were shown to be associated with specific pathways, including glycolysis as well as amino acid and nucleotide metabolism. The glucose depletion and glycolysis inhibitors 2DG and oxamate could reduce the level of PRV replication in PK-15 cells. In addition, the inhibition of the pentose phosphate pathway (PPP) resulted in an obvious decline of viral titers, but the prevention of oxidative phosphorylation in the tricarboxylic acid (TCA) cycle had a minimal effect on viral replication. Glutamine starvation resulted in the decline of viral titers, which could be restored by supplemental addition in the culture media. However, inhibition of glutaminase (GLS) activity or the supplement of 2-ketoglutarate into glutamine-deleted DMEM did not alter PRV replication in PK-15 cells. The results of the current study indicate that PRV reprograms the metabolic activities of PK-15 cells. The metabolic flux from glycolysis, PPP and glutamine metabolism to nucleotide biosynthesis was essential for PRV to enhance its replication. This study will help to identify the biochemical materials utilized by PRV replication in host cells, and this knowledge can aid in developing new antiviral strategies.
Copyright © 2021 Gou, Bian, Li, Cai, Jiang, Song, Zhang, Chu, Yang and Li.

Entities:  

Keywords:  PK-15 cells; classical attenuated strain; metabolic activity; metabolomics; pseudorabies virus (PRV); variant virulent strain

Year:  2021        PMID: 33585273      PMCID: PMC7879706          DOI: 10.3389/fcimb.2020.599087

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  27 in total

1.  Vaccinia virus requires glutamine but not glucose for efficient replication.

Authors:  Krystal A Fontaine; Roman Camarda; Michael Lagunoff
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

2.  Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1).

Authors:  Juliana L Abrantes; Cristiane M Alves; Jessica Costa; Fabio C L Almeida; Mauro Sola-Penna; Carlos Frederico L Fontes; Thiago Moreno L Souza
Journal:  Biochim Biophys Acta       Date:  2012-04-21

3.  Metabolomics approach for investigation of effects of dengue virus infection using the EA.hy926 cell line.

Authors:  Grace Birungi; Sheryl Meijie Chen; Boon Pheng Loy; Mah Lee Ng; Sam Fong Yau Li
Journal:  J Proteome Res       Date:  2010-11-05       Impact factor: 4.466

4.  Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy.

Authors:  Joshua Munger; Bryson D Bennett; Anuraag Parikh; Xiao-Jiang Feng; Jessica McArdle; Herschel A Rabitz; Thomas Shenk; Joshua D Rabinowitz
Journal:  Nat Biotechnol       Date:  2008-09-28       Impact factor: 54.908

Review 5.  Control of swine pseudorabies in China: Opportunities and limitations.

Authors:  Yuan Sun; Yuzi Luo; Chun-Hua Wang; Jin Yuan; Na Li; Kun Song; Hua-Ji Qiu
Journal:  Vet Microbiol       Date:  2015-12-19       Impact factor: 3.293

6.  A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Authors:  Moriah L Szpara; Yolanda R Tafuri; Lance Parsons; S Rafi Shamim; Kevin J Verstrepen; Matthieu Legendre; L W Enquist
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

7.  Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.

Authors:  Livia Vastag; Emre Koyuncu; Sarah L Grady; Thomas E Shenk; Joshua D Rabinowitz
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

8.  Metabolic Profiles in Cell Lines Infected with Classical Swine Fever Virus.

Authors:  Hongchao Gou; Mingqiu Zhao; Jin Yuan; Hailuan Xu; Hongxing Ding; Jinding Chen
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

9.  Glycolysis Is an Intrinsic Factor for Optimal Replication of a Norovirus.

Authors:  Karla D Passalacqua; Jia Lu; Ian Goodfellow; Abimbola O Kolawole; Jacob R Arche; Robert J Maddox; Kelly E Carnahan; Mary X D O'Riordan; Christiane E Wobus
Journal:  mBio       Date:  2019-03-12       Impact factor: 7.867

10.  Pathogenic pseudorabies virus, China, 2012.

Authors:  Xiuling Yu; Zhi Zhou; Dongmei Hu; Qian Zhang; Tao Han; Xiaoxia Li; Xiaoxue Gu; Lin Yuan; Shuo Zhang; Baoyue Wang; Ping Qu; Jinhua Liu; Xinyan Zhai; Kegong Tian
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

View more
  2 in total

1.  Metabolomics Analysis of PK-15 Cells with Pseudorabies Virus Infection Based on UHPLC-QE-MS.

Authors:  Panrao Liu; Danhe Hu; Lili Yuan; Zhengmin Lian; Xiaohui Yao; Zhenbang Zhu; Xiangdong Li
Journal:  Viruses       Date:  2022-05-27       Impact factor: 5.818

2.  RIPK3-Dependent Necroptosis Limits PRV Replication in PK-15 Cells.

Authors:  Hongchao Gou; Zhibiao Bian; Rujian Cai; Pinpin Chu; Shuai Song; Yan Li; Zhiyong Jiang; Kunli Zhang; Dongxia Yang; Chunling Li
Journal:  Front Microbiol       Date:  2021-06-04       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.